Chemours
503 hedge funds and large institutions have $3.94B invested in Chemours in 2021 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 145 increasing their positions, 137 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
503
Holders Change
+45
Holders Change %
+9.83%
% of All Funds
7.77%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.12%
New
95
Increased
145
Reduced
137
Closed
45
Calls
$49.8M
Puts
$98.5M
Net Calls
-$48.7M
Net Calls Change
+$280M
Top Buyers
| 1 |
Millennium Management
New York
|
+$58.3M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.8M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$18.2M |
| 4 |
Goldman Sachs
New York
|
+$13.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$11.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$69.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$37.4M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$35.7M |
| 4 |
SC
Sessa Capital
New York
|
-$22.9M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$21.1M |
